As shown in Fig. 5, CEP55 expression in ovarian cancer patients was associated with survival time, with the patients expressing low CEP55 in their ovarian cancer lesions surviving much longer than those with high CEP55 expression (P < 0.001). Here, CEP55 is linked to ovarian carcinoma.